Essential Pharma Announces the Acquisition of HALDOL®

Zug, Switzerland, Dec. 7 (Korea Bizwire) – Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products across key therapeutic areas, announces that it has completed the acquisition of HALDOL® (haloperidol) and HALDOL® Decanoate (haloperidol decanoate) from Janssen Pharmaceutica NV. HALDOL® is a first-generation [...]